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The purpose of this study was to examine longitudinal associations among thyroid stimulating 
hormone (TSH) levels and cognitive performance. Data collected at the first three assessment 
times, approximately 3 years apart, are reported for the survivors (n = 45) from a previously 
published cross-sectional study. Participants were aged 75-93 years at baseline, and data 
reported were collected in the Kungsholmen Project, a longitudinal project investigating aging 
and dementia. Analyses revealed that although declining verbal fluency and visuospatial 
abilities were accompanied by simultaneously declining TSH levels, the pattern of cross-
sectional and longitudinal results are interpreted such that declining TSH levels may have 
caused episodic memory deficits later on. These results were obtained in the examination of 
6-year but not 3-year change, and after removal of the cognitive variation associated with 
depressive mood symptoms. 
 




Although the deleterious effects of thyroid disease on cognitive functioning is well 
documented (e.g., Osterweil et al., 1992), the association between normal variation of thyroid 
functioning and cognitive performance in old age has been subjected to a limited number of 
reports. In one of the first published studies (Wahlin et al., 1998) we found that, within 
normal ranges, Thyroid Stimulating Hormone (TSH) but not thyroxine predicted cognitive 
performance cross-sectionally among elderly persons between 75 and 96 years. Interestingly, 
there was a strong positive relationship between levels of TSH and episodic memory 
performance, but the associations with other cognitive abilities (i.e., verbal fluency, 
visuospatial ability, short-term memory, and perceptual-motor speed) were less pronounced. 
Prinz and colleagues (1999), showed in a subsequent cross-sectional study of elderly 
euthyroid men with a mean age of 72 years that thyroxine but not trijodothyronine or TSH 
levels were related to various cognitive performance measures including tests of verbal and 
general cognitive abilities. Volpato et al. (2002), published data on physically impaired 
women, aged 65 years and older, and with normal thyroid gland function at baseline, showing 
that low baseline thyroxine but not TSH within normal ranges predicted cognitive decline 
across three years, as assessed by the Mini-Mental State Examination Scale (MMSE: Folstein 
et al., 1975). No cross-sectional associations were detected in this study. Interestingly, item 
analyses revealed that the prospective thyroxine-MMSE association was related to the 
orientation and memory aspects of the scale, both involving episodic memory components. 
Finally, van Boxtel et al. (2004), examined a random sample from the Maastricht Aging 
Study, aged 49-71 years. The test battery included a variety of tasks, among them tests of 
episodic memory. This study failed to detect any cross-sectional associations involving TSH 
and cognitive performance. 
As is evident, the results from the aforementioned studies are contradictory as to 
which indicator of thyroid functioning is the most relevant marker of cognitive performance, 
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and which domain of cognitive performance, if any, is primarily affected by thyroid hormonal 
variations. The contrasting results might be due to sample differences, where age could 
potentially constitute an explanatory factor. Thus, the inconsistencies in the work reviewed, 
may in part be due to the varying age ranges involved. Evidence showing that increasing age 
results both in growing thyroid and cognitive variability (Marrioti et al., 1995; Bäckman et al., 
1999) supports this hypothesis. Thus, increased variability in thyroid and cognitive 
functioning should be expected among the oldest persons. 
Thyroid functioning is commonly assessed by means of TSH obtained in serum. 
Although TSH is a sensitive method for detecting low values indicative of hyperfunction, 
diagnosis of hypothyroidism may require additional tests. Importantly, thyroid hormones 
increase the response of the beta-adrenergic receptor to norepinephrine, which may serve as 
an adaptive mechanism of neuromodulation (Whybrow and Prange, 1981; Dratman and 
Gordon, 1996). More specifically, low TSH levels are also associated with elevated steroid 
hormone levels within the hypothalamus-pituitary-adrenal axis (van Haasteren et al., 1996). 
Increased levels of cortisol, which is part of this circuitry, may result in hippocampal cell loss 
and impair episodic memory performance (Lupien et al., 1994). Therefore, although thyroid 
hormones may be associated with a variety of cognitive abilities, there might be a particularly 
strong link to episodic memory. 
Yet, to the best of our knowledge, no study has been published showing analyses of 
longitudinal relationships among cognitive and normal thyroid functioning involving 
longitudinal assessment of both thyroid indicators and cognition. Such analyses would permit 
safer conclusions about whether (a) there is a causal relationship between normal variations in 
thyroid functioning and cognitive performance, or (b) cognitive and thyroid functioning are 
both subject to the influence of a third causative factor or process potentially responsible for 
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the presence or absence of significant thyroid-cognition associations as documented in the 
studies published to date. 
One such factor, known to be associated deficient thyroid functioning (e.g., Brown, 
1980; Denicoff et al., 1990) and to account for TSH-cognition associations (van Boxtel et al., 
2004), is mood symptoms. Thus, in the present study, we controlled for depressive mood 
symptoms before examination of TSH-cognitive performance associations. The mood 
variable was derived from the Comprehensive Psychopathological Rating Scale (CPRS: 
Åsberg et al., 1978). In Sweden, this scale is commonly used as a basis for diagnosing major 
depression according to DSM-IV criteria. 
In the present study, we follow a sample for which cross-sectional data have already 
been reported (Wahlin et al., 1998) across two follow-up assessments separated by 
approximately three years. The three points of data collection are from now on referred to as 
T1, T2, and T3. Although both thyroxine and TSH were available at baseline, only TSH was 
considered necessary for diagnostic purposes at follow-ups within the larger project. Hence, 
this study will focus exclusively on the relationship between normal TSH variations and 
cognitive abilities. 
We hypothesised, first, that the selective relationship of normal TSH levels with 
episodic memory functioning should be detectable also with a longitudinal data design. 
Hence, we expected this selective association both cross-sectionally at T1, T2, and T3 and 
with respect to longitudinal associations among longitudinal change indicators. Second, we 
hypothesised that if longitudinal associations were detected, they would not be entirely due to 
a parallel change in TSH and cognitive functioning. Instead, we expected previous 
longitudinal change in TSH to cause differences in cognitive performance later on. Thus, in 
order to arrive at such a conclusion, some clear discrepancies in the pattern of associations 
among cross-sectional and longitudinal change data were necessary. Finally, in stating these 
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hypotheses we make the assumption that biological change (i.e., TSH) causes differences in 
cognitive functioning, and that the reverse causal direction is less likely. 
To achieve these goals, we analyzed longitudinal data collected from the surviving 
participants of the sample reported in our first study from the Kungsholmen Project on cross-
sectional associations among TSH and cognitive functioning. 
Methods 
The Kungsholmen project (KP) involves longitudinal assessment of three 
independent populations. The present sample was taken from the Kungsholmen parish of 
Stockholm, Sweden, aged 75 years and older at the first time of assessment (see Fratiglioni et 
al., 1992, for an overview of the study). Diagnosis of dementia, depression (major depression 
and dysthymia), and general anxiety disorder were made according to established criteria (i.e., 
DSM-III-R: American Psychiatric Association, 1987; DSM IV: American Psychiatric 
Association, 1994) at each phase of data collection. Cross-sectional data for the sample 
selected for longitudinal analysis (n = 200), was reported in a previous publication (Wahlin et 
al., 1998). From this sample, data collected from participants who completed the cognitive 
testing and had normal TSH values also at the first and second follow-up are reported in the 
present study (n = 45). Retest intervals for this sample were approximately 3 years (T1-T2: M 
= 2.86 years, SD = .49; T2-T3: M = 3.51 years, SD = .50). All procedures were approved by 
the ethics committee at Karolinska institutet, and in accordance with the Helsinki Declaration 
of 1975. 
Laboratory Tests 
Across all three times of assessment, the same procedure and methods were applied for the 
collection of laboratory data. Thus, blood samples were collected in the morning on the same 
day as the cognitive testing. These analyses involved a variety of health indices, of which 
TSH was selected for the present study. For the analysis of TSH, the immunoradiometric 
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method was used (Seth et al., 1984). The immunoradiometric assay is an ultrasensitive 
method that allows detection of very low TSH values, indicative of hyperthyreosis. Inter- and 
intratest variability of the method within the normal range is 2.5% and 1.5% respectively. 
 The same cutoff values as in our previous study were applied. These cutoff 
scores were chosen according to clinical recommendations in order to exclude subjects with 
potential thyroid-related disease. Thus, the lower limit for TSH was set at 0.4 mU/liter, and 
the upper limit at 5.0 mU/liter (Griffin and Solomon, 1986). For these reasons, subjects with 
TSH values outside the normal range at either of the two follow up assessments were 
excluded. In addition, for the purpose of prospective analyses, thyroxine data collected at T1 
were added to the data set. Free thyroxine levels were assessed by means of a 
radioimmunoassay method (Giles, 1982). The methods used to assess TSH and thyroxine are 
both highly reliable within normal ranges (Giles, 1982; Seth et al., 1984), as reflected by the 
variability. For thyroxine the intra-test variability is almost undetectable (.04%), and 
the inter-test variability (1%) is similar to that of TSH. 
 Next, we computed percentage change in TSH values between the three times of 
assessment. Among the three possible time frames (T1-T2, T2-T3, and T1-T3), we selected 
for further analysis the entire time range (T1-T3) and the last three years (T2-T3). This was 
done in order to compare the impact of 3-year with 6-year TSH change on cognitive 
performance at the end of the respective time interval. Since the T1-T2 range was already 
included in the T1-T3 range, it represented redundant information and was therefore 
considered only in a control analysis to be reported below. 
Mood symptoms 
Four items were selected from the CPRS (i.e., dysphoria, appetite disturbance, feelings of 
guilt, and suicidal thoughts). At each of T1-T3, the four mood symptoms were added to form 
a composite mood score with a possible range of 0-4. In order to avoid dividing by zero in the 
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computation of mood change scores, 1 was first added to all scores at T1, T2, and T3 
respectively. 
Participants 
At T1 two hundred subjects ranging in age between 75 and 96 years were selected for study 
on the basis of their euthyroid status (see Wahlin et al., 1998). As expected, a large number of 
the participants died before the two follow up assessments. At T2, 36 subjects had died, 7 
refused to participate, and 2 had moved and could not be located. At T3, another 48 persons 
had died, 5 refused to participate, and 1 person had moved. From the remaining sample, 10 
refused to take part in the blood testing at either T2 or T3, and 46 participants were excluded 
as they had TSH values outside the normal ranges at either T2 or T3. Due to the small sample 
remaining after these exclusions, we decided not to remove incident dementia cases at either 
T2 (n = 6) or T3 (n = 9). None of the participants were diagnosed with depression, dysthymia 
or general anxiety disorder at any time point, and no participants were treated with thyroid 
hormones. The remaining 45 participants were subjected to the analyses of longitudinal data 
reported in this article. Table 1 provides descriptive information for demographic, thyroxine, 
TSH, and mood symptom data. In addition, the table provides descriptive information for the 
persons excluded due to their TSH values being outside the normal range. 
________________________ 
Insert Table 1 About Here 
________________________ 
Cognitive Tests 
The same cognitive tests as reported in our 1998 publication were selected for further 
examination. However, for the digit span tests, the rank-order stability of change was 
relatively constant across individuals, resulting in reduced variance and attenuated 
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associations. These problems resulted in non-interpretable findings. Thus, we therefore 
excluded the digit span tests from the analyses. 
 In order to control for practice effects, the tasks were administered in two orders 
and, for the tests of episodic memory, five versions. These combinations were 
counterbalanced across age and time of testing. Thus, no participant received identical tests at 
any of the three test occasions. 
Episodic memory. Four episodic memory tests (requiring the participant to remember also 
that the to-be-remembered materials were presented to him/her during study, that is, the 
personal, temporal and spatial source information) comprising free recall of 12 semantically 
unrelated words presented at either rapid (2 sec/word) or slow (5 sec/word) pace, free recall of 
organizable words, and category cued recall of organizable words where presentation for the 
organizable words were 5 sec/word. In all four tasks, nouns were used as study items. 
Verbal fluency. Three fluency tasks were administered. In two letter (initial N and S) fluency 
tasks, participants were given 60 seconds to produce as many words as possible. In a third 
category fluency task, participants were asked to produce, within 60 seconds, as many 
exemplars of food as possible. 
Visuospatial ability. To assess this domain, we used the block design test from the Wechsler 
Adult Intelligence Scale - Revised (Wechsler, 1981). Standard procedures for administration 
and scoring were applied. 
Perceptual-motor speed. Shortened versions of the Trail Making A and B (TMT: Reitan and 
Davidson, 1974) were administered, and time scores were used as the outcome measure. The 
TMT was modified such that part A had a maximum score of 12 and part B had a maximum 
score of 11. This modification was done to make sure that severely impaired subjects could 
also be assessed. Both tasks were administered according to standard procedures and the time 




In order to reduce the number of dependent variables and to increase reliability, 
composite cognitive scores were created. Thus, we created a composite score for episodic 
recall of random words, where the correlations across T1-T3 were .60, .42, and .47 
respectively (ps < .01), a composite recall of organizable words, where the T1-T3 correlations 
were .89, .86, and .92 (ps < .01), a composite letter fluency score (rs .83, .69, .67, ps < .01), 
and a composite TMT score (rs .31, .40, .29, ps < .05). In all cases, the composite score 
constituted the mean of the summed scores. Missing data (< 5% in all cases) were inputed 
using the EM algorithm in SPSS. 
Finally, and similar to the TSH data, we computed for each dependent measure, 
percentage change from T2 - T3, and T1 - T3, respectively. Table 2 provides summary 
statistics for the cognitive variables across T1, T2, and T3, and the time intervals of primary 
interest. 
________________________ 
Insert Table 2 About Here 
________________________ 
 Although the demographic and dementia information were not correlated with 
any of the TSH cross-sectional or change scores (demographic ps > .05; dementia ps > .10), 
they were significantly correlated with several of the cognitive performance composite scores. 
Thus, even if the demographic and incident dementia data may not be confounded with the 
TSH effects, we considered it to be informative to generalize the results across the mean level 
of these parameters. Importantly, running the analyses reported below without these control 
variables resulted in very similar findings.  Hence, in all analyses that followed, age at 
baseline, years of education, gender, and incident dementia diagnosis at either of T2 or T3, 
and the relevant mood score were used as control variables. Data were analyzed by means of 
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hierarchical regressions, where age, education, gender, the two dummy-coded incident 
dementia diagnose variables, and the relevant mood score were entered in the first step. In the 
second step, the relevant TSH predictor variable was entered. The analyses were structured 
into four sections. First, we examined at T1, T2, and T3 the cross-sectional associations 
between TSH level and cognitive performance. As a control, we examined also whether 
thyroxine at T1 predicted T1 performance. Second, T2-T3 and T1-T3 percentage cognitive 
change was predicted from baseline TSH and thyroxine values. Third, T2-T3 and T1-T3 
percentage cognitive change was predicted from percentage TSH change in the corresponding 
time intervals. Fourth, and finally, we predicted in two separate sets of analyses cognitive 
performance at T3 with T2-T3 percentage TSH change, or T1-T3 percentage TSH change as 
predictors. Here, we added as a control analysis the prediction of cognitive performance at T2 
from percentage TSH change within the T1-T2 time frame. The results of the analyses are 
presented next. 
 Cross-sectional associations. The cross-sectional associations of TSH with 
cognitive performance were examined at each of the three points of assessment. The two 
incident dementia variables were as expected the strongest predictors among the control 
variables, accounting for significant portions of variations in several of the tasks across the 
three times of assessment. Age, gender, and education predicted performance on the fluency 
tasks, but only at T1 and T2. Number of mood symptoms were not significantly associated 
with performance at any of T1, T2, or T3 (all ps >.10), but most of the ß-weights indicated 
associations in the expected directions (i.e., more symptoms were associated with worse 
performance). Although all TSH-performance associations were in the expected direction 
(i.e., higher level of TSH indicated better performance), it approached significance for recall 
of random words only. This association was marginally significant at both T1 (  = .265, incr. 
R
2
 = .065, p = .05), and T3 (  = .273, incr. R
2
 = .064, p = .06), although the association at T2 
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was not reliable (  = .206, incr. R
2
 = .039, p = .16). Thyroxine level did not predict 
performance in any of the cognitive tasks at T1 (all ps > .45). 
 Baseline TSH and thyroxine relative to cognitive change. In two sets of separate 
analyses we examined the extent to which baseline TSH or thyroxine would predict cognitive 
change scores between T1-T3 and T2-T3, respectively, after accounting for the block of 
control variables. Results showed that both baseline TSH and thyroxine levels were unrelated 
to all cognitive change scores (all ps > .30). The impact of the control variables are reported in 
the next set of analyses. 
 TSH change relative to cognitive change. In the third set of analyses we sought 
to determine whether changing TSH values would predict changing cognitive performance. 
As indicated above, the time intervals examined were T1-T3, and T2-T3. Results are shown in 
Table 3. Note that the time intervals are combined in the table, so that the T2-T3 TSH-
cognitive change associations are shown in the upper part, and the T1-T3 associations in the 
lower part of the table. 
________________________ 
Insert Table 3 About Here 
________________________ 
As can be seen in the lower section of Table 3, TSH T1-T3 change significantly predicted 
change on the two fluency tests and on the test of visuospatial ability. In all cases, positive 
change in TSH level was associated with less decline on these tasks. No significant TSH-
cognitive performance associations were found in the T2-T3 time interval. Among the control 
variables, longer education predicted decline in TMT performance across the T2-T3 time 
interval. Apart from a single positive association between T1-T3 mood and visuospatial 
change scores, mood symptoms were unrelated to all performance scores. Unexpectedly, 
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incident dementia at T2 was positively related to cognitive change in both time intervals. The 
beta-weights for incident dementia at T3 were however in the expected directions. 
 TSH change relative to cognitive performance at T3 and T2. In the final set of 
analyses, we examined the extent to which changing TSH values would predict cognitive 
performance. Here, we selected cognitive performance at T3 as the endpoint, and regressed, 
first, the respective cognitive variable on three year TSH change (T2-T3), and second, the 
same dependent measures on six year TSH change (T1-T3). Finally, as a control analysis, we 
regressed the T2 cognitive performance scores on three year (T1-T2)  TSH change. Table 4 
shows a summary of the results obtained. 
________________________ 
Insert Table 4 About Here 
________________________ 
 As can be seen in the upper section of Table 4 where T3 cognitive data 
constitute the outcome, short-term (T2-T3) TSH change (2a) did not account for a significant 
portion of the variation in any of the tasks. This general outcome was replicated using T2 
cognitive data as the dependent measures (lower part of Table 4) and again short-term (T1-
T2) TSH change as predictor. Turning to long-term (T1-T3) TSH change, a different picture 
emerged. Looking at the upper section of Table 4, where long-term TSH change was entered 
into the regressions in the second step (2b), TSH T1-T3 change accounts for 7.2% of the 
variation in episodic recall of random words and 8.8% of the variation in episodic recall of 
organizable words. Note also that all beta-weights were positive, indicating that decline of 
TSH values was associated with worse cognitive performance, the exception being TMT 
where the negative beta-weight indicate that worse time performance was associated with 
decline of TSH. As for the control variables, across analyses, all significant associations were 
in the expected directions. Higher age, and incidence of dementia were related to lower levels 
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of performance while longer education and being a woman were related to higher levels of 
performance. Changing mood symptoms did not predict any of the cognitive performance 
scores. 
 Age by TSH interactions. In order to test the hypothesis that the chronological 
age range under scrutiny may be a factor explaining why TSH-cognition associations are not 
always detected, we computed Age X TSH and Age X TSH change cross-product interaction 
terms and repeated all analyses with the relevant interaction term entered in the third step. No 
interaction term approached significance in any of the analyses (all ps > .05). 
 Examination of outliers. Inspection of the TMT scores (see Table 2) revealed 
that one subject exhibited extreme time scores at T3. To check whether this accounted for the 
lack of effects in this particular task, this value was truncated at the next level considered to 
be a high but not extreme time score (i.e., 209 sec), and the analyses involving TMT repeated. 
Results revealed that TMT performance was still unrelated to TSH.  
 Examination of impending death. Proximity to death is known to be associated 
with decline of cognitive functioning (e.g., Small & Bäckman, 1996), a phenomenon 
sometimes referred to as ‘terminal drop’. Five of the participants in the study had died within 
one year after T3, and three of those were incident dementia cases during this study. 
Correlations showed that impending death was significantly associated with more and slightly 
increasing mood symptoms (all ps <.05), and slightly associated with most cognitive 
performance and change scores (ps >.05). No reliable association with the TSH indicators was 
found (all ps >.10), although the direction of the correlations were negative in all cases (i.e., 
impending death was associated with lower and declining TSH values. As a final control, we 
examined whether impending death accounted for the detected TSH-cognition associations by 
repeating all main analyses including death within one year after T3 as a dummy-coded 
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control variable. Results revealed that although impending death was weakly (ps >.10) 
associated with declining cognitive abilities, the main findings remained unchanged. 
Discussion 
 The chief objective of the present study was to further examine the previously 
documented cross-sectional positive associations between normal variation in levels of 
thyroid stimulating hormone and cognitive and episodic memory performance by means of 
longitudinal data. For this purpose, we used data from the Kungsholmen Project collected 
during the first three times of assessment (T1, T2, T3) between 1987 and 1996. The study is 
unique in two respects. First, associations among longitudinal thyroid and cognitive data have, 
to the best of our knowledge, not previously been reported. Second, the age range examined 
(75-93 years at baseline) is rare in this type of study. Due to high death rates and presence of 
TSH values indicative of thyroid dysfunction across T2 and T3, the original sample reported 
in the previous study (Wahlin et al., 1998) was reduced to 45 participants. We therefore 
decided to include both non-demented persons and cases of incident dementia at either of T2 
or T3. 
 Data were analyzed cross-sectionally, prospectively, and longitudinally, where 
percentage difference scores were employed to indicate change over time. The main findings 
were, first, that six year change in TSH levels were found to selectively predict episodic 
memory performance at the final assessment. This association was however not detected 
using three-year TSH change, irrespective of whether T2 or T3 cognitive data constituted the 
outcomes. Second, at the cross-sectional level of analysis, the selective association of TSH 
with episodic memory performance was detected at T1 and T3, but only for episodic recall of 
random words. In the analyses of T1-T3 and T2-T3 cognitive change predicted from baseline 
TSH and thyroxine levels, no significant association was detected. Third, turning to 
associations among change scores, a different pattern of results emerged, showing that six 
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year change in TSH was significantly associated with six year change in the two indicators of 
verbal fluency and the visuospatial ability indicator. In these analyses, the relationships to the 
two indicators of episodic memory were less pronounced and did not reach conventional 
levels of statistical significance. No reliable associations were detected in any of the analyses 
involving three year change scores, and age did not interact with TSH or thyroxine to 
influence any of the foregoing. 
 The finding that the reliable TSH-cognitive performance associations were all 
positive, both cross-sectionally and longitudinally, may seem at odds with previous studies 
showing that hypothyroidism (in which TSH values are high) constitute a risk factor for 
developing dementia at a later stage (e.g., Breteler et al., 1991; Ganguli et al., 1996). It is 
however not uncommon that the predictive power (both in terms of strength and direction) 
changes outside normal ranges (e.g., Wahlin et al., 1996) or that the predictive directions are 
best described as an inverted U-shaped form. Importantly, in this study we took great care in 
excluding persons with TSH values outside normal range at any of the three occasions of data 
collection. 
 Although the present data do not permit definite conclusions about causality, the 
outcome of the main analyses present an interesting pattern suggesting the existence of some 
direct TSH change-cognition effects, and some effects indicating that TSH levels and 
cognitive performance change in parallel, possibly due the existence of a third variable. The 
main comparison to be made is that of the results from the TSH change relative to cognitive 
change, and TSH change relative to cross-sectional cognitive differences, respectively. As 
shown in Table 3, changing TSH values were accompanied by changing letter and category 
fluency scores, and changing visuospatial ability scores. In these analyses, the TSH-episodic 
memory association failed to reach conventional levels of significance. Table 4 presents the 
opposite result, where six year change in TSH levels predicted performance on the two 
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episodic memory tests at T3, but no other cognitive ability. Thus, the results suggest that 
declining TSH levels are accompanied by parallel decline in fluency and visuospatial 
performance, while the very same TSH decline results in episodic memory deficits only at the 
end of six years change. However, it is still possible that TSH change might cause deficits in 
fluency and visuospatial performance, but that the time needed for such deficits to occur is 
longer than six years. 
 As noted, the four previously published studies present quite disparate findings. 
Prinz et al. (1999) found cross-sectional associations between thyroxine but not TSH and 
verbal and global cognitive functioning. Wahlin et al. (1998) found cross-sectional 
associations between TSH but not thyroxine and episodic memory. Volpato et al. (2002) and 
van Boxtel et al. (2004) failed to find any cross-sectional associations involving thyroxine and 
TSH, respectively, but the Volpato et al. study found that baseline thyroxine levels predicted 
future cognitive decline, particularly on tasks involving episodic memory components. Van 
Boxtel and colleagues (2004) argued that one explanation for the lack of TSH-related effects 
in their study, was that their sample was younger than that examined by Wahlin et al. (1998). 
In order to test this hypothesis, Age x TSH level cross-product interaction effects were tested, 
but similar to the present study they were found to be non-significant. However, the problem 
associated with detecting significant interaction effects are well documented (McClelland and 
Judd, 1993). Therefore, the age of the studied sample may still be a valid concern. Also, a 
study involving an age range covering both that of van Boxtel et al. (49-71 years) and our 
study (75-93 years) might still present a different outcome showing significant age by TSH 
interaction effects. However, common to all previous studies was that no information was 
available regarding longitudinal change of the thyroid indicators. In light of the present 
findings, it may be that both T4 and TSH require long-term change in order to correlate with 
cognitive performance, where TSH actually exerts an impact on episodic memory 
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functioning, while the longitudinal associations with other types of cognitive abilities are 
merely an expression of shared variation possibly caused by a third factor. Note in this 
context that we controlled for a likely third variable, that is, depressive mood symptoms. Van 
Boxtel and colleagues (2004) found mood symptoms to account for much of the TSH-
episodic memory associations in their study, while number of mood symptoms or change 
scores had little impact on the outcome variables in the current study. Whether this is a 
result of the strict selection procedure in combination with the age range studied, remains to 
be determined by future research. 
 It is noteworthy that six-year change was required to detect significant 
longitudinal associations among TSH and cognitive variations. This finding does however not 
necessarily indicate that varying TSH levels exert long-term but not short-term change effects 
on cognitive functioning. Inspection of Table 2 shows, first, that cognitive decline was larger 
across six years than three years and, second, that the variation increased proportionally to the 
means. This is in accordance with previous research showing that in order to detect reliable 
cognitive decline, six years is the minimal test interval required (e.g., Zelinski and Burnight, 
1997). Interestingly, TSH levels did not present this pattern (see Table 1). Thus it may be 
premature to draw any firm conclusions as to the time aspect of the TSH-cognition 
association. 
 The prospective analyses of baseline TSH and thyroxine regressed on cognitive 
change were included in order to replicate the study by Volpato et al. (2002). Similar to that 
study, we found that baseline TSH did not predict future decline of cognitive performance. 
However, we failed to replicate their findings that thyroxine levels at baseline predicted future 
memory decline. It is yet to be established whether this is a reliable difference, since the 
Volpato et al. study reported longitudinal data on thyroid status for only a subset of their 
participants, while we defined our sample by their normal thyroid levels at both follow-ups. 
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In a series of control analyses, we examined, first, whether the lack of TSH-
related effects on TMT performance was due to the existence of extreme scores. Second, 
proximity to death was covaried in order to check whether the results were accounted for by 
the terminal drop phenomenon. Note in this context that the terminal drop phenomenon itself 
is likely to be accounted for by various biological indicators (e.g., Berg, 1996). In brief, our 
analyses showed that although impending death was marginally associated with declining 
cognitive performance and reliably associated with increasing mood symptoms, the main 
findings were unchanged by statistical control for death within one year after the third 
assessment. Although no firm conclusion is possible here, it seems that the terminal decline 
phenomenon is not confounded with the association between individual differences in 
cognitive performance and normal TSH status.  
 Performance on the Trail Making Test was not significantly related to TSH in 
any of the analyses. We believe that this may be due to the characteristics of the task. 
Trailmaking is an omnibus test that requires multiple cognitive skills, whereas the remaining 
cognitive tasks involved in the study draw on more specific skills. Provided the relatively 
complex outcome of the analyses showing dissociations in the results depending on the ability 
being examined, the failure to find any associations with the Trail Making test may be 
expected.  
 Although it is customary to separate dementia from non-dementia in cognitive 
aging studies, we decided to include participants who were diagnosed with incident dementia 
either at the first or the second follow-up. Concerns about statistical power formed the basis 
of our decision to do so, and to instead control for dementia by means of statistical 
procedures. We did however repeat all analyses without the incident dementia subjects (data 
not shown). The pattern of results were not changed by this, but as expected few results 
approached significance. This outcome together with the absence of significant TSH - 
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dementia correlations justifies in our view the inclusion of the incident dementia cases. Also, 
the anomaly in Table 3, where incident dementia at the first follow-up was positively related 
to some of the cognitive change scores were due to a few extreme individual change scores in 
this small group (n = 6) caused by very low initial cognitive scores in two individuals. 
 In support of the results in our first cross-sectional study (Wahlin et al., 1998), 
the present data suggest a particularly strong association among individual variations in 
normal TSH levels and episodic memory performance. Saying that, one should note that the 
cognitive change scores display a mixed pattern of decline and improvement over time. This 
is commonly found in most studies (see Hultsch et al., 1998). However, the trends were most 
consistent for the episodic memory variables. Thus, the proposed selective association of 
normal TSH with episodic memory should be interpreted with caution, since this discrepancy 
across the cognitive performance measures may have contributed to this finding. In addition, 
Table 1 reveals that the sign of the TSH change scores were also somewhat inconsistent. 
Importantly, the correlations among the cross-sectional TSH variables were all positive 
and significant (rs = .54 - .69; ps < .001), and the correlations among the change scores of 
primary interest (i.e., TSH T2-T3 vs T1-T3 change; TSH T1-T2 vs TSH T1-T3 change) 
were both positive and highly significant (rs = .58 and .54, ps < .001) 
 Finally, the number of exclusions due to TSH values outside normal range may 
seem large, but was motivated by our wish to take a conservative approach in order to avoid 
spurious associations. It is known that preturbations of thyroid hormones and TSH 
concentrations in the absence of thyroid dysfunction are commonly observed in a number of 
nonthyroidal illnesses that may also exert an impact on cognitive performance (McIver and 
Gorman, 1997). Thus, although we cannot definitely confirm the excluded participants had 
thyroid illnesses, the potential impact on cognitive functioning of their borderline TSH values 
may have inflated the results obtained in this study had they been included. 
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 Hence, as a separate control, we repeated all analyses including the subjects 
with out of range TSH values. In order to minimize effects of outliers, low and high TSH 
values were truncated at the lower (i.e., 0.4 mU/liter) or upper (i.e., 5.0 mU/liter) end of the 
normal distribution. Although the increased sample size provided more power to the analyses, 
most of the TSH-cognition associations disappeared (data not shown). This was however to 
be expected, since the clinical symptomatology of hyper- or hypothyroid persons may vary 
from hyperactivity to lethargy, causing quite disparate effects on cognitive performance. 
Descriptives of the group with out of range TSH values are shown in Table 1. 
 In sum, we found that, within normal ranges, declining TSH levels were 
associated with declining verbal fluency and visuospatial abilities, but not with deficits in 
those abilities at the end of three- or six year change time windows. With respect to episodic 
memory the longitudinal TSH change relative to cognitive change associations were also 
present, although they did not approach conventional levels of statistical significance. By 
contrast, six year changes in TSH levels were positively and significantly related to 
differences in episodic memory performance at the end of the follow-up interval. The results 
suggest that although most of the association between TSH and cognitive abilities may be due 
to shared change variation, TSH may exert a direct impact on episodic memory. It is 
suggested that the mechanism for such effects are increased cortisol levels, known to affect 
episodic memory functioning in particular (Lupien et al., 1994; van Haasteren et al., 1996). In 
order to further clarify this topic, it is necessary to expand the age range under scrutiny to 
cover both younger and older participants, and to add indicators of both relevant thyroid 
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Summary Statistics for Demographic and Laboratory Data For Study Sample, and Persons 







 Study sample (n = 45) Out of range TSH (n = 46) 
  Min Max M SD  Min Max M SD 
Age at T1   75.00   92.00 84.87   3.62           75.00   93.00 78.95   3.64 
Gender (% females) 87     65     
Education (years)     7.00   18.00   9.15   3.11     7.00   18.00   9.75   3.51 
T4 at T1
 a
   12.00   23.00 14.76   2.32   12.00   21.00 15.61   2.43 
TSH at T1 
b
  .60     4.90   1.84   1.06  .50     4.90   2.07   1.08 
TSH at T2 
b
  .60     3.80   1.54     .81  .10     6.20   1.79   1.28 
TSH at T3 
b
  .42     5.00   1.60   1.11  .03     8.10    .69   1.65 
TSH % change T1-T2  -70.45 100.00  -6.68 35.73  -97.96 175.00  -10.86 50.99 
TSH % change T2-T3  -58.46 233.33   7.02 56.19  -95.91 1400.00 -32.71 227.82 
TSH % change T1-T3  -66.54 117.39  -5.48 50.12  -98.16 350.00 -67.54 74.39 
Mood symptoms at T1  0 1.5 .06 .24  0 1.5 .13 .34 
Mood symptoms at T2  0 1 .38 .49  0 3.5 .31 .69 
Mood symptoms at T3  0 3.5 .48 .87  0 3.5 .45 .91 
Mood % change T1-T2  -60 100 34 51  -50 350 21 68 
Mood % change T2-T3  -50 350 19 82  -78 250 21 70 




























Dependent Variables Min Max M SD 
EM random T1 1.00 9.00 5.11 1.78 
                    T2 1.00 9.50 5.04 1.56 
                    T3 .50 8.00 3.44 1.77 
           % change T2-T3 -75.00 57.00 -25.22 25.75 
           % change T1-T3 -75.00 104.09 -23.77 34.43 
EM organized T1 2.50 11.00 7.18 2.43 
                        T2 .00 11.50 6.62 1.97 
                        T3 .00 12.00 5.66 2.69 
           % change T2-T3 -86.78 832.16 7.00 132.85 
           % change T1-T3 -89.47 166.33 -12.32 46.63 
Letter fluency T1 .50 33.50 11.45 6.96 
                       T2 3.00 19.50 10.39 3.54 
                       T3 .00 28.50 13.00 6.20 
           % change T2-T3 -93.55 211.11 30.34 60.33 
           % change T1-T3 -93.93 940.30 58.62 162.35 
Category fluency T1 3.00 33.00 19.00 7.25 
                            T2 8.00 28.00 17.35 4.45 
                            T3 .00 36.00 20.57 9.14 
           % change T2-T3 -145.45 79.42 -13.07 44.09 
           % change T1-T3 -95.65 624.47 25.98 106.15 
Block design T1 2.00 21.00 12.61 5.02 
                      T2 2.00 21.00 12.83 4.59 
                      T3 1.00 19.00 9.09 4.62 
           % change T2-T3 -150.00 75.85 -5.50 43.95 
           % change T1-T3 -84.61 315.66 -15.13 63.85 
TMT T1 26.00 360.00 114.08 67.77 
          T2 20.00 205.00 87.21 43.56 
          T3 25.00 477.00 113.36 68.74 
           % change T2-T3 -47.34 119.19 63.79 185.27 




Hierarchical Regression Examining TSH Change Scores as Predictors of Cognitive Change 
Scores in the T1-T3 and T2-T3 Time Intervals 
 
Table 4 
Hierarchical Regression Examining TSH Change Scores as Predictors of Cognitive 
Performance Scores at T2 and T3 
 
